Recruiting
Tarlatamab in Advanced Delta-like 3 (DLL3)-Expressing Tumors Including Neuroendocrine Neoplasms
NCT06788938
- Conditions
- Advanced Tumors, DLL3-expressing Tumors, Neoplasms
- Locations
-
- UC Davis Comprehensive Cancer Center Davis, California, United States
- UCI Health Chao Family Comprehensive Cancer Center Irvine, California, United States
- University of California at Los Angeles Los Angeles, California, United States
- UC San Diego Moores Cancer Center San Diego, California, United States